Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2007
10/03/2007CN100340234C Prepn process of micron fatigue-eliminating Chinese medicine granule, capsule and tablex
10/03/2007CN100340233C Ophthalmic compositions containing a synergistic combination of three polymers
10/03/2007CN100340232C Jinshu leaf styptic mixture and its preparing method and use
10/03/2007CN100340231C Itch eliminatin gel and its preparing method
10/03/2007CN100340230C 'Ruyi Jinhuang' gel and method for preparing the same
10/02/2007US7276641 Mixture with analgesic and anti-inflammatory dissolved in an aqueous hot melt type adhesive base material of styrene-isoprene-styrene block copolymer, adhesive resin, an antioxidant, lanolin, and water; drug releasability, good bioavalability
10/02/2007US7276594 Nucleic acid-containing complex
10/02/2007US7276537 Formulations of anthraquinone derivatives
10/02/2007US7276534 Carbon-substituted diketopiperazine delivery systems
10/02/2007US7276486 Compositions for vaginal treatment
10/02/2007US7276477 Crystals of etanercept and methods of making thereof
10/02/2007US7276256 Cosmetic or healing gel for application to the human skin
10/02/2007US7276254 Emulsion/aggregation polymeric microspheres for biomedical applications and methods of making same
10/02/2007US7276253 Use of an oral dosage with quick release and storage stability: core of omeprazole, lansoprazole or pantoprazole and adjuvants; an intermediate layer having a gastric juice-resistant partially alkali neutralized polymer with cation exchange capacity, and an outer gastric juice resistant layer
10/02/2007US7276252 Material handling of toxic drugs; multilayer forms
10/02/2007US7276251 Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid
10/02/2007US7276250 Sustained release formulations of oxymorphone
10/02/2007US7276249 Phospholipid-free, having a D50 particle size of less than 500 nm, andhaving a surface stabilizer; improved pharmacokinetic profiles and reduced fed/fasted variability
10/02/2007US7276248 Conjugate having a cleavable linkage for use in a liposome
10/02/2007US7276246 Dissolvable backing layer for use with a transmucosal delivery device
10/02/2007US7276190 Process for the production of micro and/or nano particles
10/02/2007US7276057 Method, system and device for treating disorders of the pelvic floor by drug delivery to the pudendal and sacral nerves
10/02/2007US7275534 Medicament ejector with ejection port servicing
10/02/2007CA2449244C Negatively charged amphiphilic block copolymer as drug carrier and complex thereof with positively charged drug
10/02/2007CA2338551C Method of vaccination of newly hatched poultry
10/02/2007CA2271623C Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth
10/02/2007CA2261887C Covalent polar lipid conjugates with biologically-active compounds for use in salves
10/02/2007CA2251114C Treatment of arthritis disorders, rheumatoid arthritis and manifestations associated with rheumatoid disorders
10/02/2007CA2168583C Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus
09/2007
09/27/2007WO2007109731A2 Healing powder and method of use thereof
09/27/2007WO2007109605A2 Pharmaceutical compositions
09/27/2007WO2007109604A2 Pharmaceutical compositions
09/27/2007WO2007109587A2 Compositions and methods for reducing inflammation and pain associated with acidosis
09/27/2007WO2007109584A1 Temperature-and ph-responsive polymer compositions
09/27/2007WO2007109530A1 Cyclosporin a compositions
09/27/2007WO2007109523A2 Stabilized ophthalmic compositions comprising oxidatively unstable components
09/27/2007WO2007109357A2 Controlled release formulation of tolterodine
09/27/2007WO2007109303A2 Formulations of lymphokines and method of use thereof for local or both local and systemic control of proliferative cell disorders
09/27/2007WO2007109247A2 Flexible, compressed intravaginal rings, methods of making and using the same, and apparatus for making the same
09/27/2007WO2007109244A2 Novel nanoparticles for delivery of active agents
09/27/2007WO2007109069A2 Hydrophobic derivatives of natural biodegradable polysaccharides and uses thereof
09/27/2007WO2007109057A2 Solid dosage form containing a taste masked active agent
09/27/2007WO2007108775A1 Cell-adhesive polyelectrolyte material for use as membrane and coating
09/27/2007WO2007108618A1 Water-soluble organometallic nanoparticles and method for preparing the same
09/27/2007WO2007108463A1 Solid preparation having improved solubility
09/27/2007WO2007108031A2 An ophthalmic pharmaceutical composition containing amphiphilic polyaspartamide copolymers
09/27/2007WO2007108004A2 S-alkylisothiouronium derivatives for the treatment of inflammatory diseases
09/27/2007WO2007107358A1 Microparticles comprising a crosslinked polymer
09/27/2007WO2007107328A2 Subcutaneous implants containing a degradation-resistant polylactide polymer and a lh-rh analogue
09/27/2007WO2007107305A2 Treatment of triple receptor negative breast cancer
09/27/2007WO2007107304A2 An efficient method for loading amphoteric liposomes with nucleic acid active substances
09/27/2007WO2007106997A1 Novel poly(ethylene oxide)-block-poly(ester) block copolymers
09/27/2007WO2007106960A1 Controlled-release floating dosage forms
09/27/2007WO2007106957A1 Multiple units controlled-release floating dosage forms
09/27/2007WO2007092755A3 Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
09/27/2007WO2007089878A3 Sutures and anti-scarring agents
09/27/2007WO2007083309A3 Method and apparatus for forming delivery devices for oral intake of an agent
09/27/2007WO2007073932A3 Protein-based delivery system for overcoming resistance in tumour cells
09/27/2007WO2007064191A8 Method for obtaining hollow particles
09/27/2007WO2007062435A3 Patch
09/27/2007WO2007057717A3 Pharmaceutical device for the administration of substances to patients
09/27/2007WO2007054565A3 New stabilized galenic formulations comprising lansoprazole and their preparation
09/27/2007WO2007053393A3 Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride
09/27/2007WO2007047646A3 Substituted dihydro-isoindolones useful in treating kinase disorders
09/27/2007WO2007041596A3 Compositions and methods for the treatment of cancer
09/27/2007WO2007040997A3 Pharmaceutical dosage forms having immediate release and/or controlled release properties
09/27/2007WO2007030434A3 Transdermal drug delivery devices containing o-desmethyl venlafaxine (odv) or its salts
09/27/2007WO2007026180B1 Improvements in the stabilisation of biological materials
09/27/2007WO2007026125A3 Anti-viral topical gel formulations containing a diuretic such as furosemide and/or a cardiac glycoside such as digoxin
09/27/2007WO2007025092A3 Stabilized and preserved ketotifen ophthalmic compositions
09/27/2007WO2007017331A3 Immediate release therapeutic systems for improved oral absorption of 7- [ (e) -tert-butyloxyiminomethyl] camptothecin
09/27/2007WO2007011819A3 Ferritin as a therapeutic target in abnormal cells
09/27/2007WO2007001845A3 Methods and systems for coating particles
09/27/2007WO2007000764A3 Compositions and methods for enhancement of sexual function
09/27/2007WO2006128469A3 Blends of inactive particles and active particles
09/27/2007WO2006043083A8 Liposomes enclosing a radionuclide and a cytotoxic agent for combination therapy
09/27/2007WO2005099751A3 Apparatus and method for transdermal delivery of influenza vaccine
09/27/2007WO2005018623A3 Parenteral and oral formulations of benzimidazoles
09/27/2007US20070226175 Automated medical safety monitoring systems and methods
09/27/2007US20070225617 Standardized swallow challenge medium
09/27/2007US20070225613 Method of esophageal function testing with a standardized thixotropic swallow challenge medium
09/27/2007US20070225369 Ophthalmic composition for treating tear dysfunction
09/27/2007US20070225361 Dimeric compounds and their use as anti-viral agents
09/27/2007US20070225359 Dimeric compounds and their use as anti-viral agents
09/27/2007US20070225342 Nicotinic Acid Compositions For Treating Hyperlipidemia and Related Methods Therefor
09/27/2007US20070225341 Nicotinic Acid Compositions For Treating Hyperlipidemia and Related Methods Therefor
09/27/2007US20070225337 Novel Co-Precipitate of Amorphous Rosiglitazone
09/27/2007US20070225234 Topical formulation of oil-in-water type as a carrier for providing a reduced irritant effect
09/27/2007US20070224283 Pharmaceutical compositions comprising crosslinked amine polymer with repeat units derived from polymerization of tertiary amines
09/27/2007US20070224282 Fine Dispersion of Sparingly Soluble Drug and Process for Producing the Same
09/27/2007US20070224281 Sustained-Release Preparations Containing Topiramate and the Producing Method Thereof
09/27/2007US20070224280 Novel nanoparticles for delivery of active agents
09/27/2007US20070224279 Stabilization of chemical compounds using nanoparticulate formulations
09/27/2007US20070224278 Triamcinolone composition; injected into eye; stability; mixture of corticosteroid particles and sodium hyaluronate in aqueous carrier
09/27/2007US20070224277 Hyaluronic acid-based cross-linked nanoparticles
09/27/2007US20070224276 Dry Powder Pharmaceutical Composition, Its Preparation Process and Stable Aqueous Suspension Obtained from Such Composition
09/27/2007US20070224275 Selenium-based biocidal formulations and methods of use thereof
09/27/2007US20070224274 Polymer Particles Containing Active Agents
09/27/2007US20070224273 Multifunctional Supramolecular Hydrogels as Biomaterials
09/27/2007US20070224272 Method and composition for burned skin
1 ... 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 1379 1380 1381 ... 2991